Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.
Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, Sagesaka YM, Hong WK, Papadimitrakopoulou V.
Tsao AS, et al. Among authors: tang xm.
Cancer Prev Res (Phila). 2009 Nov;2(11):931-41. doi: 10.1158/1940-6207.CAPR-09-0121.
Cancer Prev Res (Phila). 2009.
PMID: 19892663
Free PMC article.
Clinical Trial.